Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for generalised myasthenia gravis (gMG).

LITTLE ROCK, Ark. — A new federal tax break touted as a win for service workers may not be quite the windfall it first appears. As part of the recently passed “Big Beautiful Bill,” a sweeping budget ...

LITTLE ROCK, Ark. — A new federal tax break touted as a win for service workers may not be quite the windfall it first appears. As part of the recently passed “Big Beautiful Bill,” a sweeping budget ...